CureZone   Log On   Join

CureZone > Books > Too Profitable To Cure by Brent Hoadley, Ph.D.
 


Too Profitable To Cure
by Brent Hoadley, Ph.D. [edit]

Too Profitable To Cure
********** 10 Stars!
Price: US$ 14.95, Available worldwide on Amazon.com
Check Availability from: Canada or from United Kingdom
ISBN: 097766101
Book Site

Description

This is the first time an overview on a most important history of an ongoing dramatic story of diabetic patients in need of natural insulins has been written.  Prof.Dr. Med. Arthur Teuscher

Dr. Arthur Teuscher is one of the world's foremost authroities on insulin. And in this excerpt from a recent essay on the FDA by the International Medical Veritas Association:

"The stories go on and on without limit (regarding FDA injustices) but one of the most foul and least heard about or understood is the story of insulin told by Dr. Brent Hoadley in his book Too Profitable to Cure. Human rDNA insulin was pushed through the FDA in the early 1980s in an incredibly short time despite scientists objecting about the high incidence of adverse events like severe hypoglycemia being found. Since the introduction of this genetically engineered insulin there has been a 350% increase in "dead in bed" syndrome (diabetics dying in their sleep from low blood sugars)."
With the ripping explosion in diabetes facing the entire world's population this could shape up to be the largest and most hidden medical fiasco ever. Dr. Hoadley, a diabetic himself, writes, "The human insulin product so quickly approved was not equal to the beef or pork insulin products that have been proven safe over a period of 70 years of use. The only advantage of human insulin is the fact that the product is considerably less expensive to produce than animal insulins and results in greater profitability for diabusiness." What is it to the FDA that the mortality rate, which prior to 1982 was less than 4% from iatrogenic hypoglycemia, exploded to present estimates of 13%? Multiply this rate increase by the huge increase in diabetes and then add in additional deaths of those killed by diabetics in auto-accidents and we have a steadily increasing number of deaths to lay at the door of the FDA. Today it is now virtually impossible for Americans, and most people around the world to even purchase these earlier safer versions of insulin." Mark Sircus Ac., OMD, Director,International Medical Veritas Association http://imva.info/

Too Profitable To Cure is a book ALL diabetics should read!  Diabetes is a shining example of the pharmaceutical industry's criminal pursuit of profits.  Patients' health, patients' lives, patients' freedom---all are fair game in the quest for limitless wealth and unbridled profits.   Arm yourself with knowledge!

Diabetes is a shining example of the pharmaceutical industry's criminal pursuit of profits.  Patients' health, patients' lives, patients' freedom---all are fair game in the quest for limitless wealth and unbridled profits.   Arm yourself with knowledge!  In this book you will learn how the pharmaceutical industry creates and maintains chronic disease in its pursuit of unholy profits, and at the expense of our health. From the government agencies--HHS, FDA, CDC, NIH--to our institutions of higher learning, from charitable advocates, like the American diabetes Association, to the powerful American Medical Association; from the media to our politicians...all are inextricably intertwined and dancing to the tune choreographed by a higher power....Big Pharma.


Brent Hoadley, Ph.D. (Biography)

Brent Hoadley grew up in Vermont. After graduating from the University of Vermont, he obtained a Ph.D. in plant science from Kansas State University. At the age of 14, he was diagnosed with Type 1 diabetes. The impact of the disease, coupled with his scientific background, influenced both his career and avocation choices.

Living with diabetes for over 50 years, he has witnessed many changes in the treatment of the disease...but is distressed that the cure is no closer now than when he was diagnosed. From a not-unbiased viewpoint, he addresses the current state of healthcare for those who suffer from chronic diseases, and contends that profit, not humanitarianism, is driving American healthcare. As an entrepreneur/inventor, he is aware, and appreciates the profit motive that drives capitalism. However, he feels the bottom line should not be tainted with the smell of dead bodies. With Yankee pragmatism, he identifies culprits and urges activism as a countermeasure.


 


 

Donate to CureZone

Contact Us - About - Sponsors - Stats

Link Exchange - Add URL - How To Exchange Links?

Terms of Service - Privacy Policy - Spam Policy - Disclaimer - Guidelines & Rules

CureZone Newsletter is distributed in partnership with https:www.netatlantic.com


Copyright 2020  curezone.com

0.4688 sec from 18.213.192.104